Evaluation of Lactocare probiotic effects on the immune system in patients with type II diabetes

Phase 2

• Conditions: type 2 diabetes.; Type 2 diabetes without complications; E11.9

• Registration Number: IRCT20220727055564N1
• Lead Sponsor: Zahedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 August 2022

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Having a willingness and informed consent to participate in the study
Having clinical symptoms of type 2 diabetes
Confirmation of type 2 diabetes based on clinical symptoms and diagnostic tests by a specialist doctor
No recent history of inflammatory diseases
No history of receiving anti-inflammatory drugs
No history of taking corticosteroid drugs
Absence of immune system diseases and immune deficiencies

Exclusion Criteria

History of heart diseases including: blood pressure, heart failure, heart attack in the last month
History of autoimmune diseases including: type 1 diabetes, multiple sclerosis, MS, lupus erythematosus, various types of vasculitis, rheumatism, Crohn's disease, etc.
History of liver diseases including: liver cirrhosis and hepatitis in the past year
History of underlying lung diseases such as: asthma, bronchiolitis, respiratory allergies, bronchiectasis, COPD
History of organ transplant in the last three months
People with a history of alcohol consumption
Taking immunosuppressive drugs

Study & Design

• Study Type: interventional
• Study Design: Not specified